| Parameters |
HIV-1 infected children |
Matched healthy controls |
p values |
| VC (L) |
3.37 ± 0.72 (2.19-4.93) |
3.69 ± 1.1 (2.51-6.58) |
0.44 |
| FEV1 (L) |
2.90 ± 0.64 (2.05-4.59) |
3.25 ± 1.0 (2.21-5.53) |
0.34 |
| FEF25-75 (L/s) |
3.46 ± 0.96 (2.27-6.16) |
4.08 ± 1.4 (2.55-7.40) |
0.21 |
| FEV1 / FVC (%) |
88 ± 6% (77-98) |
90 ± 5% (82-98) |
0.43 |
| TLCO (ml/mn/Hg mm) |
24.18 ± 9.3 (15.7-57.5) |
NA |
NA |
| Parameters (ppv) |
HIV-1 infected children |
Matched healthy controls |
|
| VC |
101.4 ± 14.7% |
103.5 ± 15.5% |
0.98 |
| FEV-1 |
92.6 ± 12.5% |
100.2 ± 13.9% |
0.052 |
| FEF25-75 |
98.1 ± 21.2% |
112.1 ± 24.6% |
0.14 |
| FEV1 / FVC |
91.9 ± 7.7% |
97.1 ± 6% |
<0.0001 |
| TLCO |
102.9 ± 23.8% |
NA |
|
mean ± standard deviation and range for spirometric values. HIV-1 vertically
infected children (n: 17) and healthy matched control (n: 17). Units: (L) liter, (L/s)
liter per second, (ml/min/Hg mm) milliliter per minute per Hg millimeter. NA: non
available, ppv: percentage of predicted value. Mean ± standard deviation for
spirometric values expressed as percentages of predicted values according to the
anthropometric data of each patient.
p values: Mann-Whitney comparison |
